The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review
- PMID: 29474713
- PMCID: PMC5862021
- DOI: 10.1093/ehjqcco/qcw018
The role of mHealth for improving medication adherence in patients with cardiovascular disease: a systematic review
Abstract
Cardiovascular disease is a leading cause of morbidity and mortality worldwide, and a key barrier to improved outcomes is medication non-adherence. The aim of this study is to review the role of mobile health (mHealth) tools for improving medication adherence in patients with cardiovascular disease. We performed a systematic search for randomized controlled trials that primarily investigated mHealth tools for improving adherence to cardiovascular disease medications in patients with hypertension, coronary artery disease, heart failure, peripheral arterial disease, and stroke. We extracted and reviewed data on the types of mHealth tools used, preferences of patients and healthcare providers, the effect of the mHealth interventions on medication adherence, and the limitations of trials. We identified 10 completed trials matching our selection criteria, mostly with <100 participants, and ranging in duration from 1 to 18 months. mHealth tools included text messages, Bluetooth-enabled electronic pill boxes, online messaging platforms, and interactive voice calls. Patients and healthcare providers generally preferred mHealth to other interventions. All 10 studies reported that mHealth interventions improved medication adherence, though the magnitude of benefit was not consistently large and in one study was not greater than a telehealth comparator. Limitations of trials included small sample sizes, short duration of follow-up, self-reported outcomes, and insufficient assessment of unintended harms and financial implications. Current evidence suggests that mHealth tools can improve medication adherence in patients with cardiovascular diseases. However, high-quality clinical trials of sufficient size and duration are needed to move the field forward and justify use in routine care.
Figures
Comment in
-
Improving medical adherence in cardiovascular disease management with mHealth technologies.Eur Heart J Qual Care Clin Outcomes. 2016 Oct 1;2(4):231-232. doi: 10.1093/ehjqcco/qcw034. Eur Heart J Qual Care Clin Outcomes. 2016. PMID: 29474718 No abstract available.
References
-
- Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009;119:3028–3035. - PubMed
-
- World Health Organization. Adherence to long-term therapies: evidence for action. World Health Organization; 2003. http://www.who.int/chp/knowledge/publications/adherence_introduction.pdf. (7 January 2016).
-
- Baroletti S, Dell'Orfano H. Medication adherence in cardiovascular disease. Circulation 2010;121:1455–1458. - PubMed
-
- National Institutes of Health. Morbidity & mortality: 2012 chart book on cardiovascular, lung, and blood diseases. National Institutes of Health; 2015. https://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf. (5 August 2015).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical